Our Recommendations
New Publications
- Dolutegravir Resistance in Malawi’s National HIV Treatment Program (2022)
- Sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy (2022)
- Clinic-based survey of acquired HIV drug residence (2021)
- HIV drug resistance report 2021 (2021)
- HIV drug resistance strategy, 2021 update (2021)
Filter
26
Featured
New Publications
8
Language
Document type
No document type
14
Guidelines
6
Studies & Reports
5
Strategic & Response Plan
1
Countries / Regions
Western and Central Europe
2
Malawi
1
Africa
1
South Africa
1
Authors & Publishers
Publication Years
Category
HIV & STI
6
Policies & Guidelines HIV & TB
1
Studies & Reports
1
Toolboxes
Guidelines
HIV drug resistance
July 2017
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Version 9.0
Octobre 2017
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
Technical Report
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
